Skip to content
Pharma Observatory a Scientist.com platform

Organization (Industry)

RESEARCH CORPORATION PTY. LTD.

ClinicalTrials.gov lists RESEARCH CORPORATION PTY. LTD. as lead sponsor of 23 trials. It has 3 active development programs and 1 approved asset.

AU Industry
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

7 0 2005 2026

Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.

2026 is partial: 7 registered with a 2026 start date. The dashed outline is the pace from the 2 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 2.4 trial starts a year over the five years to September, under the 5 a year the method needs.

This page covers RESEARCH CORPORATION PTY. LTD.: 23 lead-sponsored trials and 3 legal-entity registrations.

Get the RESEARCH CORPORATION PTY. LTD. report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Disease areas (20)

Shown in this order: most trials first.

Disease areas
Disease area Trials
Foreign Bodies 4
Foreign-Body Reaction 4
Inflammation 4
Surgical Wound 4
Granuloma, Foreign-Body 2

Trials by start year as sponsor or collaborator (10)

Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Show the table of trials by start year as sponsor or collaborator
Trials by start year as sponsor or collaborator
Year Trials started
2026 (partial year) 7
2025 1
2024 7
2023 2
2014 5
2012 1
2011 1
2010 2
2007 1
2005 1

Recruitment duration, a model prediction: none of the 23 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

Active development programs (3)

Shown in this order: max phase, then active trials.

Active development programs
Drug Disease area Max phase Trials
Standardized Tramadol Elastomeric Analgesia Pump Pain Not reported 1
Standardized Tramadol Elastomeric Analgesia Pump Postoperative Pain Not reported 1
Standardized Tramadol Elastomeric Analgesia Pump Drug-Related Side Effects and Adverse Reactions Not reported 1

Approved assets (1)

Approved assets
Drug Trials
Indocyanine Green 1

Journals published in (6)

Shown in this order: most published in first.

Journals published in
Journal Publications
Plastic and reconstructive surgery 3
Plastic and reconstructive surgery. Global open 3
Aesthetic plastic surgery 1
Aesthetic surgery journal. Open forum 1
EFORT open reviews 1

US granted patents (1)

Patents are not classified by disease area in the source, so this is the organization's overall portfolio, not a split by disease.

US granted patents
US patents granted Granted in the last 5 years Most recent grant
2 0 1991-10-08

FDA inspection record (1)

FDA inspection record
Latest classification Inspections
NAI 2

Organization relationships (2)

Shown in this order: most evidence first.

Organization relationships
Related organization Relationship Evidence
FORUM Pharmaceuticals (United States) Co sponsors trial with 1
Somnus Therapeutics, Inc. Co sponsors trial with 1

Latest dated events (32)

Shown in this order: newest first.

Latest dated events
Date Event Source
2026-10-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-10-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-10-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-10-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))
2026-10-01 Trial started Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI))

Biomarker capability evidence (12)

Shown in this order: tier desc, then gene symbol.

Biomarker capability evidence
Gene Role Evidence
CYP2D6 Trial sponsor Named in trial inclusion criteria
CYP2D6 Trial CRO (operations) Named in trial inclusion criteria
PIP Trial CRO (operations) Named in trial exclusion criteria
PIP Trial sponsor Named in trial exclusion criteria
PIP Trial sponsor Named in trial exclusion criteria

On Scientist.com

RESEARCH CORPORATION PTY. LTD. is listed as a research supplier in the Scientist.com network.

Source: Scientist.com supplier network

Not on this page

Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, sponsor delivery record, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, clia clinical laboratory certificates, and biomarkers this organization publishes on.

Work with SRL Research on Scientist.com

For prices, more details, or to contact SRL Research, visit Scientist.com.

Sign in to Scientist.com to open this supplier in your organization's marketplace.